Purchase Order 80NSSC25PB102
Award Date
7/9/25
Potential Completion Date
7/8/26
Potential Value
$16K
Federal Agency
Shared Services Center
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
This is a firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. for $91,615.99. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This is not a set-aside contract. Illumina has...
This firm fixed-price purchase order was awarded by the U.S. Secret Service, a civilian federal agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $80,727.00, is for the maintenance of an Illumina MiSeq sequencing system. The performance period extends through April 24, 2025. This award is not associated with a set-aside designation. Illumina has been awarded numerous prime federal contracts and grants to provide...
This is a federal contract award to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, by the Office of Administrative Services Procurement Management Branch of the U.S. government. The contract, valued at $213,646.31, is for the delivery of ILLUMINA SUPPLIES, including various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and consumables. The contract is a firm fixed price Blanket Purchase Agreement (BPA) call, with no set-aside...
This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $103,374.14 contract is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. The contract has no set-aside designation. Illumina has previously been awarded prime...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $40,892.00, is for the provision of Illumina's products and services to support genomic sequencing and analysis. Illumina has previously been awarded prime federal contracts and subcontracts by various agencies like the NIH, CDC, USDA, and VA to provide...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Illumina, Inc. The $24,163.80 contract is for the provision of various Illumina sequencing systems, reagents, and related services. Illumina is a manufacturer of genetic and genomic analysis instrumentation and solutions. The contract does not have a set-aside designation. Illumina has previously received other prime federal contracts and sub-awards from...
This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $26,800.70 award is for the provision of biological kits, Illumina sequencing equipment, and associated services. Illumina has been a frequent supplier of sequencing technology and expertise to federal agencies like the NIH, CDC, USDA, and VA. This award does not utilize any set-aside...
This is a firm-fixed-price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $60,625.54 contract is for the procurement of Illumina's genetic sequencing platforms, reagents, consumables, and related services. The award does not utilize any set-aside designations. Illumina is a leading manufacturer of advanced genomic sequencing technologies and has been awarded...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc. for $17,598.18. The contract does not have a set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables and support services, to support genomic sequencing and analysis for research and diagnostic applications across several...